US Patent Issued to The Trustees of the University of Pennsylvania on June 30 for "Nucleoside-modified RNA for inducing an immune response against SARS-CoV-2" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,613, issued on June 30, was assigned to The Trustees of the University of Pennsylvania (Philadelphia).

"Nucleoside-modified RNA for inducing an immune response against SARS-CoV-2" was invented by Norbert Pardi (Philadelphia) and Drew Weissman (Wynnewood, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions and methods for inducing an adaptive immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a subject. In certain embodiments, the present invention provides a composition comprising a nucleoside-modified nucleic acid molecule encoding a SARS-CoV-2 antigen, adjuvant, or a...